Pitcairn Co. lessened its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 6.4% during the third quarter, HoldingsChannel.com reports. The firm owned 2,741 shares of the financial services provider’s stock after selling 186 shares during the period. Pitcairn Co.’s holdings in CME Group were worth $605,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of CME. KKM Financial LLC lifted its holdings in CME Group by 7.0% during the 3rd quarter. KKM Financial LLC now owns 10,630 shares of the financial services provider’s stock worth $2,346,000 after buying an additional 695 shares during the last quarter. Cerity Partners LLC raised its position in shares of CME Group by 60.0% during the 3rd quarter. Cerity Partners LLC now owns 72,917 shares of the financial services provider’s stock valued at $16,089,000 after acquiring an additional 27,332 shares in the last quarter. Keyes Stange & Wooten Wealth Management LLC raised its position in shares of CME Group by 3.0% during the 3rd quarter. Keyes Stange & Wooten Wealth Management LLC now owns 3,585 shares of the financial services provider’s stock valued at $791,000 after acquiring an additional 103 shares in the last quarter. Leelyn Smith LLC lifted its stake in CME Group by 4.5% during the third quarter. Leelyn Smith LLC now owns 11,259 shares of the financial services provider’s stock worth $2,484,000 after purchasing an additional 480 shares during the last quarter. Finally, Eagle Asset Management Inc. boosted its holdings in CME Group by 9.5% in the third quarter. Eagle Asset Management Inc. now owns 91,583 shares of the financial services provider’s stock worth $20,667,000 after purchasing an additional 7,960 shares during the period. Institutional investors own 87.75% of the company’s stock.
CME Group Stock Performance
CME stock opened at $229.37 on Tuesday. The company has a 50-day simple moving average of $223.86 and a 200 day simple moving average of $211.19. The company has a market capitalization of $82.66 billion, a P/E ratio of 24.12, a PEG ratio of 5.28 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.74.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio is presently 48.37%.
Insider Activity
In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 1.57 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock worth $3,441,063 over the last 90 days. 0.30% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on the stock. Piper Sandler raised their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Oppenheimer raised their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 target price on shares of CME Group in a report on Thursday, October 24th. Morgan Stanley raised their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Finally, The Goldman Sachs Group upped their price objective on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $224.47.
View Our Latest Stock Report on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- What Makes a Stock a Good Dividend Stock?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What to Know About Investing in Penny Stocks
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.